1.Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer
Sanghyun AN ; Hongjin SHIM ; Kwangmin KIM ; Bora KIM ; Hui-Jae BANG ; Hyejin DO ; Hyang-Rae LEE ; Youngwan KIM
Annals of Coloproctology 2022;38(2):97-108
We aimed to review whether pretreatment inflammatory markers reflect the short- and long-term outcomes of patients with colon cancer, rectal cancer, colon and rectal cancers, and metastatic colorectal cancer (CRC). We found that pretreatment complete blood count and blood chemistry tests reflect short-term and long-term oncological outcomes in patients with CRC. Specifically, in patients with colon cancer, hypoalbuminemia was associated with worse postoperative morbidity, mortality, and inferior survival. In patients with rectal cancer, elevated neutrophil-lymphocyte ratio (NLR) and thrombocytosis were associated with postoperative complications, poor overall survival (OS), and disease-free survival (DFS). A high C-reactive protein/albumin ratio (CAR) was associated with poor OS and DFS. In patients with metastatic CRC, increased NLR and platelet-lymphocyte ratio (PLR) were associated with poor OS, DFS, and progression-free survival (PFS). In addition, high CAR and a low albumin/globulin ratio on blood chemistry tests were associated with poor OS and PFS. Although universal cut-off values were not available, various types of pretreatment laboratory markers could be utilized as adjuncts to predict prognosis in patients with CRC.
2.Postoperative Bowel Function After Anal Sphincter-Preserving Rectal Cancer Surgery: Risks Factors, Diagnostic Modalities, and Management
Chris George CURA PALES ; Sanghyun AN ; Jan Paolo CRUZ ; Kwangmin KIM ; Youngwan KIM
Annals of Coloproctology 2019;35(4):160-166
Low anterior resection syndrome (LARS) refers to a disturbance of bowel function that commonly manifests within 1 month after rectal cancer surgery. A low level of anastomosis and chemoradiotherapy have been consistently found to be risk factors for developing LARS. Thorough history taking and physical examination with adjunctive procedures are essential when evaluating patients with LARS. Anorectal manometry, fecoflowmetry, and validated questionnaires are important tools for assessing the quality of life of patients with LARS. Conservative management (medical, physiotherapy, transanal irrigation), invasive procedures (neuromodulation), and multimodal therapy are the mainstay of treatment for patients with LARS. A stoma could be considered when other treatment modalities have failed. An initial meticulous surgical procedure for rectal cancer, creation of a neorectal reservoir during anastomosis, and proper exercise of the anal sphincter muscle (Kegel’s maneuver) are essential to combat LARS. Pretreatment counseling is a crucial step for patients who have risk factors for developing LARS.
Anal Canal
;
Chemoradiotherapy
;
Counseling
;
Diagnosis
;
Humans
;
Manometry
;
Physical Examination
;
Quality of Life
;
Rectal Neoplasms
;
Risk Factors
3. Anti-MMP-2 and MMP-9 activity of Salsola komarovii Iljin extract and its solvent fractions
Jung-Ha KIL ; Fatih KARADENIZ ; Jung OH ; Jung LEE ; Chang-Suk KONG ; Ga YU ; Chang-Suk KONG ; Hojun KIM ; Junse KIM ; Youngwan SEO
Asian Pacific Journal of Tropical Biomedicine 2020;10(10):460-469
Objective: To investigate matrix metalloproteinases (MMP)-2 and MMP-9 inhibitory effect of Salsola komarovii Iljin, an edible halophyte with health beneficial effects. Methods: Salsola komarovii crude extracts (SKI), and solvent (n-hexane, 85% aq. MeOH, n-BuOH, and H